Zobrazeno 1 - 10
of 1 624
pro vyhledávání: '"Stephen M Stahl"'
Autor:
Marco Solmi, Christoph U Correll, Michael Berk, Pierre-Michel Llorca, Michael Eriksen Benros, Michele Fornaro, Jasmina Mallet, Mathieu Urbach, Martina Billeci, Jayashri Kulkarni, Marion Leboyer, David Misdrahi, Romain Rey, Franck Schürhoff, Iris E C Sommer, Stephen M Stahl, Baptiste Pignon, Fabrice Berna
Publikováno v:
BMJ Mental Health, Vol 26, Iss 1 (2023)
Question This umbrella review and guidelines aimed to provide evidence to support the rational choice of selected adjunctive therapies for schizophrenia.Study selection and analysis Following the Preferred Reporting Items for Systematic Reviews and M
Externí odkaz:
https://doaj.org/article/820308cd85b64899b75d54e1ac2b8259
Publikováno v:
Frontiers in Pharmacology, Vol 3 (2012)
The Dopamine Hypothesis of Schizophrenia is actively being challenged by the NMDA Receptor Hypofunctioning Hypothesis of Schizophrenia. The latter hypothesis may actually be the starting point in neuronal pathways that ultimately modifies dopamine pa
Externí odkaz:
https://doaj.org/article/d109005ad1da4e6c857d3724f6d2b6cc
Autor:
Stephen M. Stahl, Gorica Djokic
Publikováno v:
European Neuropsychopharmacology. 73:108-118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20fba715dc3af334ebcde0632cf73669
https://doi.org/10.1016/j.euroneuro.2023.04.015
https://doi.org/10.1016/j.euroneuro.2023.04.015
Autor:
Ezio Bettini, Stephen M. Stahl, Sara De Martin, Andrea Mattarei, Jacopo Sgrignani, Corrado Carignani, Selena Nola, Patrizia Locatelli, Marco Pappagallo, Charles E. Inturrisi, Francesco Bifari, Andrea Cavalli, Andrea Alimonti, Luca Pani, Maurizio Fava, Sergio Traversa, Franco Folli, Paolo L. Manfredi
Publikováno v:
Pharmaceuticals, Vol 15, Iss 8, p 997 (2022)
Excessive Ca2+ currents via N-methyl-D-aspartate receptors (NMDARs) have been implicated in many disorders. Uncompetitive NMDAR channel blockers are an emerging class of drugs in clinical use for major depressive disorder (MDD) and other neuropsychia
Externí odkaz:
https://doaj.org/article/a9489daf59de4062bfa561e5de1336f9
Autor:
Ezio Bettini, Sara De Martin, Andrea Mattarei, Marco Pappagallo, Stephen M. Stahl, Francesco Bifari, Charles E. Inturrisi, Franco Folli, Sergio Traversa, Paolo L. Manfredi
Publikováno v:
Pharmaceuticals, Vol 15, Iss 7, p 882 (2022)
REL-1017 (esmethadone) is a novel N-methyl-D-aspartate receptor (NMDAR) antagonist and promising rapid antidepressant candidate. Using fluorometric imaging plate reader (FLIPR) assays, we studied the effects of quinolinic acid (QA) and gentamicin, wi
Externí odkaz:
https://doaj.org/article/790f963de6d14b359c5bec9f2fbe1fc3
Publikováno v:
Trends in Pharmacological Sciences. 43:1098-1112
Modern interest in muscarinic acetylcholine receptor (mAChR) activators for schizophrenia began in the 1990s when xanomeline, an M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63266f26f1cb0b097ede00179965f79c
https://doi.org/10.1016/j.tips.2022.09.006
https://doi.org/10.1016/j.tips.2022.09.006
Autor:
Seetal Dodd, Trevor R. Norman, Harris A. Eyre, Stephen M. Stahl, Arnie Phillips, André F. Carvalho, Michael Berk
Publikováno v:
CNS Spectrums. :1-11
Psilocybin is a tryptamine alkaloid found in some mushrooms, especially those of the genus Psilocybe. Psilocybin has four metabolites including the pharmacologically active primary metabolite psilocin, which readily enters the systemic circulation. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132e36f53ea981f76e07a0c8943fbf33
https://doi.org/10.1017/s1092852922000888
https://doi.org/10.1017/s1092852922000888
Autor:
Michael E. Thase, Stephen M. Stahl, Roger S. McIntyre, Tina Matthews-Hayes, Donna Rolin, Mehul Patel, Amanda Harrington, Vladimir Maletic, W. Clay Jackson, Eduard Vieta
Publikováno v:
The Primary Care Companion For CNS Disorders. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c685a150fb837cfdb3e27b38c209ae8c
https://doi.org/10.4088/pcc.22m03322
https://doi.org/10.4088/pcc.22m03322
Publikováno v:
Journal of Psychopharmacology. 36:428-438
Schizophrenia manifests as loss of brain volume in specific areas in a progressive nature and an important question concerns whether long-term treatment with medications contributes to this. The aim of the current PRISMA systematic review was to sear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec26c64e52a9e45e380fea440f41a90
https://doi.org/10.1177/02698811221087645
https://doi.org/10.1177/02698811221087645
Publikováno v:
CNS spectrums. 27(1)
Dementia-related psychosis (DRP) is prevalent across dementias and typically manifests as delusions and/or hallucinations. The mechanisms underlying psychosis in dementia are unknown; however, neurobiological and pharmacological evidence has implicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb15b8eba7a0f2ec83b9c42fec19614
https://pubmed.ncbi.nlm.nih.gov/32811586
https://pubmed.ncbi.nlm.nih.gov/32811586